Vitamin B3 Supplement Shows No Significant Benefit in Early Parkinson’s Trial

Nicotinamide riboside is a form of vitamin B3 that raises levels of a substance cells use.

In a randomized trial, it did not significantly help people with early Parkinson’s disease.

The result means the trial did not show that the supplement improves the disease.